Type of MS: RRMS|SPMS
Treatment mode of action: To explore safety and tolerability
Number of Subjects: 15
Medication: siponimod
Location: California
Institutions: SC3 Research, Pasadena
Contact Information
Roxanne Cabading, ext. 799
(626) 250 2070
roxanne.cabading@neurosearch-usa.com